MetaCap

Pliant Therapeutics Statistics

NASDAQ: PLRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.5951-0.0249 (-4.02%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Pliant Therapeutics by the numbers

Pliant Therapeutics has a market capitalization of $36.9 million based on 61.99M shares outstanding. With trailing EPS of $-1.46, Pliant Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.6% below its 50-day average and 47.1% below its 200-day average.

Average daily trading volume is 408.93K shares, or about $243,354 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

PLRX valuation vs. peer median

PLRX compared with the median of 8 peer companies
MetricPLRXPeer medianDifference
Market cap$36.89M$36.44M+1%
Avg. volume408.93K193.59K+111%

Peer median across 8 companies: SDEV, GRCE, CNTB, CUE, DWTX, VERU, ATNM, TLPH.

Valuation

Price and trading

Previous close
0.62
Open
0.6001
Day range
0.5719 – 0.6139
52-week range
0.5719 – 1.67
52-week change
-61.61%
Beta
—
Volume
933.40K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
36.89M
Forward Pe
-0.43
Eps
-1.46
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.67
Week52 Low
0.57
Avg Volume
408.93K
Shares Outstanding
61.99M
Ma50
0.92
Ma200
1.12
Earnings Date
Nov 12, 2026
Pct From52w High
-64.37%
Pct From52w Low
4.06%

Related